Login / Signup

Differences in avidity of anti-post-translationally modified protein antibodies in mouse models and rheumatoid arthritis patients: not one-size-fits-all.

Stef van der MeulenLu ZhangJacqueline M F van VeenendaalDiane van der WoudeLeendert Adrianus Trouw
Published in: RMD open (2024)
Keyphrases
  • rheumatoid arthritis patients
  • disease activity
  • mouse model
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • protein protein
  • amino acid